ArticleACS medicinal chemistry letters2025
Novel Pyrrolidinyl Derivatives as HCN2 Modulators for Treating Central Nervous System and Psychiatric Disorders, Namely, Autism, Mood Disorders and Schizophrenia.
Ram W SabnisPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.